Cystatin C–Based eGFR Changes during Gender-Affirming Hormone Therapy in Transgender Individuals

1Center of Expertise on Gender Dysphoria, Department of Internal Medicine, Amsterdam University Medical Centers, Location VU Medical Center, Amsterdam, The Netherlands

2Department of Endocrinology and Metabolism, Amsterdam University Medical Centers, Location VU Medical Center, Amsterdam, The Netherlands

3Department of Endocrinology, Ghent University Hospital, Ghent, Belgium

4Section of Endocrinology, Department of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado

5Division of Renal Diseases and Hypertension, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado

6Diabetes Center, Amsterdam University Medical Centers, Location VU Medical Center, Amsterdam, The Netherlands

7Amsterdam Cardiovascular Sciences, VU University, Amsterdam, The Netherlands

Correspondence: Dr. Sarah A. van Eeghen, Department of Internal Medicine, Amsterdam University Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands. Email: [email protected]

See related editorial, “Does Gender-Affirming Hormone Therapy Affect the Kidney?,” on pages 1524–1526.

留言 (0)

沒有登入
gif